Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Takeda Pharmaceutical Co. (TAK) had Pre-Tax Income of $-939.54M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$29.74B |
|
$-1.01B |
|
$10.37B |
|
$19.37B |
|
$29.70B |
|
$41.03M |
|
$-980.58M |
|
|
Pre-Tax Income |
$-939.54M |
$-939.54M |
|
$-1.00B |
|
$-1.00B |
|
$-1.00B |
|
$-1.00B |
|
$41.03M |
|
$4.80B |
|
3.15B |
|
3.15B |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$20.40B |
|
$14.00B |
|
$81.98B |
|
$102.38B |
|
$18.69B |
|
$28.84B |
|
$34.64B |
|
$53.33B |
|
$49.04B |
|
$-11.86B |
|
$49.04B |
|
3.16B |
|
| Cash Flow Statement Financials | |
$6.87B |
|
$-2.44B |
|
$-3.28B |
|
$2.54B |
|
$3.93B |
|
$1.39B |
|
$480.31M |
|
$-2.06B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.09 |
|
-- |
|
-- |
|
0.37 |
|
0.66 |
|
65.12% |
|
0.14% |
|
0.14% |
|
16.14% |
|
-3.16% |
|
-3.38% |
|
$5.75B |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
1.13 |
|
5.14 |
|
70.99 |
|
-2.05% |
|
8.46% |
|
-0.98% |
|
-1.29% |
|
$15.52 |
|
$1.83 |
|
$2.18 |
|